IVA TIRRES
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner PHOENIX, AZ NPI 1558972752
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner AZ Insulet Corporation All categories
General Payments — all program years on this page
$3,703.64
- Category: General Payments
- Program years: PY2021–2024
- Record count: 136
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,521.09 across 67 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,521.09 | 67 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Insulet Corporation | $198.47 | 9 |
| Acerta Pharma LLC | $118.65 | 1 |
| Lilly USA, LLC | $114.68 | 7 |
| Xeris Pharmaceuticals, Inc. | $113.98 | 5 |
| ABBVIE INC. | $98.03 | 5 |
| Radius Health, Inc. | $95.08 | 4 |
| Amgen Inc. | $84.90 | 3 |
| SANOFI-AVENTIS U.S. LLC | $77.21 | 2 |
| Amneal Pharmaceuticals LLC | $73.99 | 4 |
| Corcept Therapeutics | $72.59 | 4 |
| MannKind Corporation | $68.81 | 3 |
| DEXCOM, INC. | $61.84 | 3 |
| RECORDATI_RARE_DISEASES_INC. | $61.28 | 3 |
| Medtronic, Inc. | $37.55 | 2 |
| Novo Nordisk AS | $32.66 | 1 |
| Currax Pharmaceuticals LLC | $27.31 | 2 |
| Abbott Laboratories | $26.56 | 1 |
| Averitas Pharma Inc. | $25.34 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.53 | 1 |
| CeQur Corporation | $21.62 | 1 |
| Astellas Pharma US Inc | $20.75 | 1 |
| Tandem Diabetes Care, Inc. | $18.37 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $17.99 | 1 |
| Esperion Therapeutics, Inc. | $14.62 | 1 |
| Ascensia Diabetes Care US Inc. | $14.28 | 1 |
By program year
Records — PY2024 (67)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.